UBS AG - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS AG ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2014$61,548,000
-29.8%
1,338,887
-18.3%
0.04%
-35.3%
Q2 2014$87,641,000
-1.6%
1,638,745
-1.6%
0.07%
-13.9%
Q1 2014$89,021,000
+3.4%
1,666,119
+3.3%
0.08%
-1.2%
Q4 2013$86,090,000
+10.9%
1,612,470
+4.2%
0.08%0.0%
Q3 2013$77,613,000
-4.4%
1,547,007
-4.8%
0.08%
-17.5%
Q2 2013$81,227,0001,625,5310.10%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2013
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders